Re: aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial

Andrew B. Rosenkrantz, Natasha E. Wehrli, Thais C. Mussi, Samir Taneja, Michael J. Triolo

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish (US)
    JournalEuropean Journal of Radiology
    DOIs
    StatePublished - 2014

    Cite this